ViroMed Co., Ltd. is a leading biotechnology company headquartered in Seoul, Korea. With a US presence in Atlanta, the company has established itself as one of the most scientifically advanced R&D companies in the global biopharmaceutical industry. ViroMed's mission is to discover and develop innovative biopharmaceuticals for human diseases. The company has a diverse pipeline of novel biologics and herbal therapeutics focused on cardiovascular disease, cancer, and immune disorders. They are currently conducting multiple clinical studies in the US, Korea, and China. ViroMed is publicly listed on KOSDAQ (084990). ViroMed Laboratories, a member of Labcorp's Specialty Testing Group, is an FDA-registered laboratory that provides infectious disease testing for human cells, tissues, and cellular and tissue-based products (HCT/Ps) donor clients. They perform donor testing at Labcorp's premier laboratory campus in Burlington, North Carolina. With over a decade of experience serving the tissue donor industry, ViroMed Laboratories has been awarded ISO15189 certification, ensuring the highest quality test offerings. The company prides itself on its quality improvement process and dedicated account management staff, which provides exceptional customer service.
Headquarters
21, Magok Central 8-Ro 7-Gil, Gangseo-Gu
Seoul; Seoul;
Contact Details: Purchase the Viro Med Co.,Ltd. report to view the information.
Website: http://www.viromed.co.kr
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service